Connect your AI

CalAmp CAMP Change in Other Assets

Change in Other Assets at other companies

Ionis PharmaceuticalsIONS

$7.39M-40.2%

Stoke Therapeutics, Inc.STOK

$3.59M+192%

Rapport Therapeutics, Inc.RAPP

-$814K-199%

MeiraGTx Holdings plcMGTX

-$1.28M—

Taysha Gene Therapies, Inc.TSHA

$794K-24.5%

CytomX TherapeuticsCTMX

$887K-26.2%

Other financials

Income statement

Revenue$1.3M+50.8%

Operating income-$13.1M+0.2%

Net income-$18.3M-47.4%

EPS (diluted)-$0.32+48.4%

Balance sheet

Cash & equivalents$100.8M+97.9%

Total debt$2.1M-73.2%

Total equity$30.9M-40.1%

Total assets$105.5M+68.0%

Cash flow

Operating cash flow-$11.0M+23.1%

CapEx--100%

Free cash flow-$11.0M+24.6%

Valuation

Market cap$226.92M+666%

Enterprise value$128.2M-3,860%

P/S57.7×+47.8×

Profitability

Operating margin-1,335.2%-512pp

Net margin-2,193.7%-581pp

FCF margin-1,254%—

Returns & leverage

Return on equity-209.3%—

Debt / equity0.1×-0.1×

Current ratio6.1×-1.9×

Where this comes from

Reported directly by CalAmp in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.

The official record: CalAmp’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about CalAmp's change in other assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is CalAmp's change in other assets?: CalAmp (CAMP) reported change in other assets of -$974K in Q1 2026.
How has CalAmp's change in other assets changed year-over-year?: CalAmp's change in other assets decreased by 14014.3% year-over-year, from $7K to -$974K.
What does change in other assets mean?: Change in miscellaneous assets affecting operating cash flow.